ADHD Slows Speech in Poor Hearing: Evidence from Eye Movements

Published Date: 02 Mar 2023

A new study by Prof. Boaz Ben-David and Rony Lemel of Reichman University's Baruch Ivcher School of Psychology has found that attention deficit hyperactivity disorder (ADHD) causes slow and difficult understanding of words.

Read Full News

Latest News

Deep Dive: Is the Autism Definition Too Broad?

A category broad enough to capture every patient who benefits from ASD-informed care may leave the most vulnerable behind.

Can You Ban Anti-Vax Family From Rural Practice?

Ethicist Art Caplan discusses the case of a physician considering banning an anti-vax family from his practice during a measles outbreak.

Chasing Bigger Weight Loss Demands New Playbook

In what he calls the ‘Weight Loss Olympics,’ Robert Gabbay, MD, PhD, explains why the focus on the next generation of multiagonists must turn to targeted comorbidity-driven engineering.

Toxicity, Censoring, and the Limits of Trial Reporting

Dr Bishal Gyawali breaks down the trial reporting pitfalls that clinicians should watch for amid the excitement of ASCO 2026.

The Case for Screening Parents at the Pediatric Visit

The parents’ mental health affects the child’s mental health.

Microvascular Disease and MACE: Unmasking the High Risk

Dr JoAnn Manson reviews a new prospective study highlighting how coronary microvascular dysfunction independently drives MACE risk, emphasizing the urgent need for targeted therapies.

Todays Updates

Smartphone App Detects Eye Cancers From Photos

A smartphone app that analyzes images of the eye may enable early screening for cancers of the eye surface, flag lesions at high risk for specialist review, and expand access beyond clinics.

Todays Updates

Smartphone App Detects Eye Cancers From Photos

A smartphone app that analyzes images of the eye may enable early screening for cancers of the eye surface, flag lesions at high risk for specialist review, and expand access beyond clinics.

Latest News

A category broad enough to capture every patient who benefits from ASD-informed care may leave the most vulnerable behind.

Ethicist Art Caplan discusses the case of a physician considering banning an anti-vax family from his practice during a measles outbreak.

In what he calls the ‘Weight Loss Olympics,’ Robert Gabbay, MD, PhD, explains why the focus on the next generation of multiagonists must turn to targeted comorbidity-driven engineering.

Dr Bishal Gyawali breaks down the trial reporting pitfalls that clinicians should watch for amid the excitement of ASCO 2026.

The parents’ mental health affects the child’s mental health.

Dr JoAnn Manson reviews a new prospective study highlighting how coronary microvascular dysfunction independently drives MACE risk, emphasizing the urgent need for targeted therapies.

News All Time

Colonoscopy Follow-Up After Stool Test Determines CRC Risk

Patients who had a positive fecal occult blood test but didn’t follow through with a colonoscopy had a fourfold higher risk for colorectal cancer than the general population.

Continue Treat-to-Target ULT Throughout Gout Remission

Dutch data support continuation over discontinuation of urate-lowering therapy to achieve a serum urate level of 0.36 mmol/L in people with gout that is in remission.

STI Diagnoses Drop, but Syphilis in Women Rises

England saw its sharpest fall in STI diagnoses in years in 2025, though syphilis trends in women are moving in the wrong direction.

Menopause Shapes Low-Dose Tamoxifen Benefit After DCIS

‘Baby TAM’ is a good bet to prevent breast cancer after DCIS, but the effects are different before and after menopause.

Two Phase 3 Trials Challenge Chemotherapy in Frontline NSCLC

Phase 3 data on sunvozertinib for EGFR exon 20 insertions and sacituzumab tirumotecan plus pembrolizumab for PD-L1-positive disease show significant PFS gains over current standards.

Delaying Ophthalmic Care May Boost Psychosis Risk

Delayed ophthalmic care is associated with increased risk for various types of psychosis, including brief psychotic disorder and schizoaffective disorder, new research shows.

Nearly 10% AxSpA Patients Meet Difficult-to-Manage Criteria

Approximately 1 in 10 patients with axial spondyloarthritis fulfill the criteria for difficult-to-manage disease; higher spinal pain scores and fibromyalgia are linked to difficult-to-manage disease.

Expert Witness Side Gigs: Good Pay, Rewarding Work

Expert witness work includes chart review and court appearances. It can pay handsomely and some physicians find it intellectually engaging. Is it right for you?

Venetoclax-Based Regimen Shows Promising Survival in Ph- ALL

A phase 2 study evaluates the efficacy and safety of a venetoclax plus pediatric-inspired chemotherapy regimen in adolescents and adults with Ph- ALL.

Young Adults Who Smoke, Vape Cannabis May Face Lung Issues

Young adults who both vape and smoke cannabis have higher odds of developing functionally important respiratory symptoms than nonusers.

RAS Drug Nearly Doubles Survival in Mets Pancreatic Cancer

In a 500-patient phase 3 trial, daraxonrasib extends median overall survival to 13.2 vs 6.7 months for chemotherapy in second-line metastatic pancreatic cancer.

NHS Failing Frail Patients as GPs Overwhelmed by Targets

GPs assessed just 17% of older patients for frailty in 2024-25, well below the 100% required by their contract, MPs warn.

Nurses Could Be the Key to Better Self-Care for IBD Patients

A nurse-patient ‘mutuality’ shows a positive association with self-care behaviors in adults with inflammatory bowel disease.

Fulcrum Scraps Sickle Cell Drug Program After FDA Raises Cancer-risk Concerns

Fulcrum Therapeutics said on Monday it would stop developing its experimental sickle-cell disease drug ⁠after the U.S. Food and Drug Administration raised cancer-risk...